In fact, in individuals carrying BRCA1/BRCA2 germ‐line mutations predisposing to breast and ovarian cancer, screening and prevention protocols have demonstrated their efficacy in terms of gain of life expectancy 38. The gene discussed is BRCA1; the disease is ovarian cancer.